Chief Executive Officer
As a diabetic, Chris had the idea to set up a business that would help people focus on their areas of highest risk. An experienced Sales Director within the Pharmaceutical Industry, Chris brings an understanding of what it is like to have diabetes and a view of how this can be improved – created from his own experience but also from working in the Pharmaceutical Diabetes area for many years with Healthcare Professionals and other people with diabetes. Intellin is the result of Chris’ dedication and passion.
Chief Operating Officer
Rory has a proven track record in starting up Pharmaceutical businesses in many different specialised sectors. Rory’s most recent role was as SVP and GM at InterMune UK&I where he set up the UK and Irish businesses over a 4 year period until their successful acquisition by Roche. Rory’s background is in Sales and Marketing and he has a passion for ensuring we improve the delivery of care to patients.
Non Executive Chairman
Former CEO of EMIS Group and Director of the UK market-leader in diabetic retinopathy eye screening software and outsourced screening provision.
40 years’ experience as founder and leader of successful tech companies.
Expert in integrating tech into the NHS.
Dr Vijay Barathan
Executive at Catapult Ventures
Catapult Ventures, Previously CIO at Netscientific Plc and investment banker looking after IPO, M&A and secondary fundraising.
Vijay also has a degree in Medicine and a BSc in Development Neurobiology.
Full stack web and mobile developer with 20+years coding and tech experience, a love of the tech and a knack of making things work, especially keen on automated testing and bug fixing.
Photographer and self-taught designer with 7+ years of experience, a background in pharmaceutical business and a passion for problem-solving.
Academic Advisors/Clinical Team
Dr Natasha H Patel
Consultant Diabetologist at Guy’s & St Thomas’ in London, with an EMBA from Imperial. Natasha has a track record of working across boundaries and a keen interest in the implementation of innovation and digital technology.
Dr May Meleigy
Medical Health Writer at Dasman Diabetes Institute
May has a PhD in immunology and writes about various health topics including diabetes, other chronic diseases, nutrition and lifestyle choices, as well as positive psychology. May enjoys translating scientific research into layman’s language, to educate and raise awareness to improve health and prevent disease. She has written pieces in BMJ and appeared on TV as a guest speaker on Orascom TV, Kuwaiti TV and CBC Egypt.
Dr Judith Anders
Judith qualified as a podiatrist in 1994 and worked as a specialist diabetes podiatrist treating patients with chronic foot ulcers. Following completion of her MSc in Practitioner Research Methods, she moved into industry where she led a diabetic foot health awareness programme, working closely with people with diabetes, HCP’s and experts in patient information. In 2013 Judith was awarded her PhD entitled “Undertaking Perceptions of Foot Health in Diabetes” which she completed at Lancaster University. She is passionate about improving preventative foot care for people with diabetes through effective education and support.
Diabetes Specialist Dietitian at NHS and Lead Sports Nutritionist at Loughborough College
Jacqui, in addition to her role at Loughborough, educates people with diabetes on nutritional strategies to improve blood sugar control both in group settings and 1:1 consultations. She also provides support and advice for people with diabetes in hospital consultant led clinics.
Diabetes Blog Writer
Helen is an experienced Technical Project, Product and Sales Manager within the telecommunications market. Helen was diagnosed in her mid thirties with type 1 whilst getting on with full and busy life. Helen writes a blog for Diabetes UK, in which she advocates , through personal experience, the belief that diabetes does not prohibit a full and adventurous life.
Our background is in Pharmaceuticals and Health Economics
We bring the disciplines of proving efficacy and value, through clinical trials and evidence, to the mobile health market.